More than 300 years after farmers had begun growing hemp as a staple crop in the United States, the endocannabinoid system (ECS) was discovered in the 1990s by researchers studying bioactive compounds in the Cannabis sativaplant. Since that time, cannabinoid receptors have been discovered in many different areas of the human body, such as the brain, digestive tract, and immune system, to name a few. Research continues to reveal diverse physiological functions of the ECS, unique properties of endogenous (endocannabinoids) and exogenous (phytocannabinoids) cannabinoids, and strategies to support ECS tone and function. In this talk, Erik Lundquist, MD explores phytocannabinoids (e.g., cannabidiol [CBD]) found in hemp extract, including bioactive properties and a growing body of literature informing potential therapeutic applications.
Erik Lundquist, MD is the founder and medical director of the Temecula Center for Integrative Medicine. He is a member of the American Holistic Medical Association as well as the Institute for Functional Medicine. He specializes in thyroid disorders, chronic and adrenal fatigue, women’s health, digestive disorders, type 2 diabetes, and metabolic syndrome.
Dr. Lundquist attended Occidental College in LA, where he graduated with a BA in Kinesiology and Biology. He received his medical degree from St. Louis University School of Medicine and completed his Family Medicine residency at Naval Hospital Camp Pendleton, where he served as Chief Resident. Dr. Lundquist spent eight years in active military duty in Iraq as a battalion surgeon with the Marine Corps, as well as at the Naval Hospital in Naples, Italy. Dr. Lundquist is board certified with the American Board of Family Medicine, as well as with the American Board of Integrative Holistic Medicine.